LITTLE ROCK — Arkansas will receive $945,406 as part of a national settlement with Pfizer Inc. to resolve allegations that the drug company unlawfully promoted Zyvox, an antibiotic, and Lyrica, a nerve-pain medication.

Pfizer agreed to pay a combined $42.9 million to Arkansas and 32 other states in the settlement.

The states alleged that Pfizer made misleading and unsubstantiated claims about the benefits of Zyvox over a similar antibiotic. There apparently was no substantial evidence to support the claim.

The states also alleged that Pfizer marketed Lyrica for some off-label, or unapproved, uses.

A consent judgement was filed Wednesday in Pulaski County circuit court to settle the state’s claims against Pfizer.

Settlement proceeds will go to the Attorney General’s Consumer Education and Enforcement Fund, a spokesman for Attorney General Dustin McDaniel said.